HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A corrigendum has been published All Versions of this Article: 289/2/H578    most recent 00958.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in AJP - Heart Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Gonzales, R. J. Articles by Krause, D. N. Search for Related Content PubMed PubMed Citation Articles by Gonzales, R. J. Articles by Krause, D. N.

Testosterone treatment increases thromboxane function in rat cerebral arteries

Department of Pharmacology, College of Medicine, University of California, Irvine, California

Submitted 14 September 2004 ; accepted in final form 4 March 2005

We previously showed that testosterone, administered in vivo, increases the tone of cerebral arteries. A possible underlying mechanism is increased vasoconstriction through the thromboxane A₂ (TxA₂) pathway. Therefore, we investigated the effect of chronic testosterone treatment (4 wk) on TxA₂ synthase levels and the contribution of TxA₂ to vascular tone in rat middle cerebral arteries (MCAs). Using immunofluorescence and confocal microscopy, we demonstrated that TxA₂ synthase is present in MCA segments in both smooth muscle and endothelial layers. Using Western blot analysis, we found that TxA₂ synthase protein levels are higher in cerebral vessel homogenates from testosterone-treated orchiectomized (ORX+T) rats compared with orchiectomized (ORX) control animals. Functional consequences of changes in cerebrovascular TxA₂ synthase were determined using cannulated, pressurized MCA segments in vitro. Constrictor responses to the TxA₂ mimetic U-46619 were not different between the ORX+T and ORX groups. However, dilator responses to either the selective TxA₂ synthase inhibitor furegrelate or the TxA₂-endoperoxide receptor (TP) antagonist SQ-29548 were greater in the ORX+T compared with ORX group. In endothelium-denuded arteries, the dilation to furegrelate was attenuated in both the ORX and ORX+T groups, and the difference between the groups was abolished. These data suggest that chronic testosterone treatment enhances TxA₂-mediated tone in rat cerebral arteries by increasing endothelial TxA₂ synthesis without altering the TP receptors mediating constriction. The effect of in vivo testosterone on cerebrovascular TxA₂ synthase, observed here after chronic hormone administration, may contribute to the risk of vasospasm and thrombosis related to cerebrovascular disease.

thromboxane synthase; cerebral circulation; vascular smooth muscle; endothelium

Related articles in AJP - Heart:

Corrigendum

AJP - Heart 2005 289: H2754. [Full Text]  

This article has been cited by other articles:

				P. D. Patel and R. R. Arora Review: Endothelial dysfunction: A potential tool in gender related cardiovascular disease Therapeutic Advances in Cardiovascular Disease, April 1, 2008; 2(2): 89 - 100. [Abstract] [PDF]

				D. N. Krause, S. P. Duckles, and D. A. Pelligrino Influence of sex steroid hormones on cerebrovascular function J Appl Physiol, October 1, 2006; 101(4): 1252 - 1261. [Abstract] [Full Text] [PDF]